Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Navarro Soriano (VALENCIA, Spain). Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma. 975

Member's Comments

No comment yet.

Related content which might interest you: Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Inflammatory markers in relation to cachexia in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Inflammatory markers in COPD patients with and without cachexia Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 Obesity and inflammatory markers in adult-onset asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 IL-33 in patients with severe uncontrolled allergic asthma Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Inflammatory mediators in COPD patients with and without alpha-1-antitrypsin deficiency Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011